Ginkgo Bioworks Holdings Inc at Goldman Sachs Global Healthcare Conference Transcript
Good morning. Thanks for joining us. I'm Matt Sykes, the Life Science Tools and Diagnostics analyst at Goldman Sachs. I had the pleasure of welcoming Ginkgo Bioworks to our conference today, Anna Marie Wagner, Senior Vice President of Corporate Development. Anna Marie, thanks for joining us.
Thanks for having me.
Maybe if you could just kind of start out by sort of setting the stage and going over some of the key highlights this year, the opportunities ahead for Ginkgo. I mean, I know you've announced recently a couple of pretty important partnerships and maybe go through some of those.
Sure. And I don't like to assume that people know
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
